SBP’s newly recruited vice president of Discovery Medicine, Muhammad Al-Hajj, PhD, is leading the charge across a bridge connecting our research discoveries with resources to develop new therapies for cancer patients. His job requires him to have one foot in the research labs and one foot out dancing with commercial pharma, biotech, and venture capital companies willing to fund the development of new cancer drugs.
Institute News
Meet the “drug hunter”
